A similar change was also observed in LFD and ob/ob mice, although some trabecular bone parameters of LFD and ob/ob mice induced by rosiglitazone did not reach statistical significance ( Fig. 4 H).
← all excerpts
CMHX008, a PPARγ partial agonist, enhances insulin sensitivity with minor influences on bone loss.
1
—
—